Jackson A L, Walters C S
Infect Immun. 1972 Oct;6(4):545-9. doi: 10.1128/iai.6.4.545-549.1972.
CD-1 mice immunized with sheep red blood cells (SRBC) or Escherichia coli lipopolysaccharide (LPS), developed splenic plaque-forming cells (PFC) producing low-molecular-weight antibody; these cells were detected by means of purified rabbit antisera to mouse gamma(1), gamma(2a), and gamma(2b) immunoglobulins. In contrast to SRBC, the primary gamma(1) response to LPS was absent and gamma(2a) and gamma(2b) PFC were detected irregularly. Both immunogens elicited a secondary cellular response in all three subclasses without a corresponding increase in "direct" or gamma(M) PFC. An increase in serum bactericidal antibody following a second injection of LPS was not parallelled by an increase in splenic gamma(M) PFC; it might therefore involve the synthesis of gamma(2) complement-fixing antibody.
用绵羊红细胞(SRBC)或大肠杆菌脂多糖(LPS)免疫的CD-1小鼠,产生了分泌低分子量抗体的脾斑块形成细胞(PFC);这些细胞通过纯化的兔抗小鼠γ(1)、γ(2a)和γ(2b)免疫球蛋白抗血清进行检测。与SRBC相反,对LPS的初次γ(1)反应缺失,γ(2a)和γ(2b) PFC检测结果不规律。两种免疫原均在所有三个亚类中引发了二次细胞反应,而“直接”或γ(M) PFC没有相应增加。第二次注射LPS后血清杀菌抗体增加,但脾γ(M) PFC没有相应增加;因此,这可能涉及γ(2)补体结合抗体的合成。